Palladin, Cytoskeletal Associated Protein (PALLD) (Middle Region) Peptide
PALLD
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5673466
Aperçu rapide pour Palladin, Cytoskeletal Associated Protein (PALLD) (Middle Region) Peptide (ABIN5673466)
Antigène
PALLD
(Palladin, Cytoskeletal Associated Protein (PALLD))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Séquence
- RRPRSRSRDS GDENEPIQER FFRPHFLQAP GDLTVQEGKL CRMDCKVSGL
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti- PALLD Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PALLD (Palladin, Cytoskeletal Associated Protein (PALLD))
-
Sujet
-
This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.
Alias Symbols: MYN, PNCA1, CGI151, SIH002, CGI-151
Protein Size: 777 -
ID gène
- 23022
-
NCBI Accession
- NM_001166108, NP_001159580
Antigène
-
Vous êtes ici:
